APA (7th ed.) Citation

Sabe, H., Inoue, A., Nagata, S., Imura, Y., Wakamatsu, T., Takenaka, S., & Tamiya, H. Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma. Wiley.

Chicago Style (17th ed.) Citation

Sabe, Hideaki, Akitomo Inoue, Shigenori Nagata, Yoshinori Imura, Toru Wakamatsu, Satoshi Takenaka, and Hironari Tamiya. Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma. Wiley.

MLA (9th ed.) Citation

Sabe, Hideaki, et al. Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma. Wiley.